HIGHLIGHTS
- who: Heba M. Attash et al. from the Department of Clinical Pharmacy, College of Pharmacy, University of Mosul, Ninevah, Iraq have published the article: Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study, in the Journal: Vaccines 2022, 10, 186. of /2022/
- what: This study was conducted to evaluate the incidence of adverse effects among HCWs after receiving Pfizer, AstraZeneca, and Sinopharm vaccines in Iraq.
SUMMARY
A study conducted by Hatmal et_al, 2021 in Jordan, to report the incidence of adverse effects among . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.